Mass screening for prostate cancer: A comparative study in Natori, Japan and Changchun, China

被引:27
作者
Kuwahara, M [1 ]
Tochigi, T
Kawamura, S
Ogata, Y
Xu, N
Wang, HL
Zhang, HF
Li, SW
Li, XM
Zhao, XJ
机构
[1] Miyagi Canc Ctr, Div Urol, Natori, Miyagi 9811293, Japan
[2] Jilin Univ, Coll Basic Med, Dept Pathophysiol, Changchun, Peoples R China
关键词
D O I
10.1016/S0090-4295(02)02093-9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To study the natural background of prostate cancer in Japan and China, mass checks with prostate-specific antigen (PSA)-based screenings were performed using identical procedures in Natori, Japan and Changchun, China. Methods. For 7 years (1995 to 2001) in Natori, Japan, and for 3 years (1998 to 2000) in Changchun, China, 2212 Japanese and 3566 Chinese men older than 55 years were mass checked by PSA-based screening (serum PSA cutoff value 4.1 ng/mL). Results. The PSA-positive rates (PSA 4.1 ng/mL or greater) and cancer detection rates in the screened persons of Natori and Changchun were 8.5% and 5.2% (P < 0.0005) and 2.1% and 0.8% (P <0.0001), respectively. When the number of cancer cases detected was adjusted to a 100% biopsy rate for men who were PSA positive in both cities, the cancer detection rate was estimated at 2.3% and 1.3% in Natori and Changchun, respectively. This difference was also significant (P < 0.01). Conclusions. The results indicate that the percentage of PSA-positive men 55 years or older in Changchun was lower than that in Natori. The analysis of the results suggests that the prostate cancer incidence and prevalence in Changchun, China are lower than those in Natori, Japan. UROLOGY 61: 137-141, 2003. (C) 2003, Elsevier Science Inc.
引用
收藏
页码:137 / 141
页数:5
相关论文
共 11 条
  • [1] Ajiki W, 2000, JPN J CLIN ONCOL, V30, P318
  • [2] [Anonymous], TUMOR
  • [3] [Anonymous], 1997, TNM CLASSIFICATION M
  • [4] COMPARISON OF DIGITAL RECTAL EXAMINATION AND SERUM PROSTATE-SPECIFIC ANTIGEN IN THE EARLY DETECTION OF PROSTATE-CANCER - RESULTS OF A MULTICENTER CLINICAL-TRIAL OF 6,630 MEN
    CATALONA, WJ
    RICHIE, JP
    AHMANN, FR
    HUDSON, MA
    SCARDINO, PT
    FLANIGAN, RC
    DEKERNION, JB
    RATLIFF, TL
    KAVOUSSI, LR
    DALKIN, BL
    WATERS, WB
    MACFARLANE, MT
    SOUTHWICK, PC
    [J]. JOURNAL OF UROLOGY, 1994, 151 (05) : 1283 - 1290
  • [5] IRVINE RA, 1995, CANCER RES, V55, P1937
  • [6] KAWAMURA S, 2000, MED REV, V72, P1
  • [7] Three-year results of the Finnish prostate cancer screening trial
    Määttänen, L
    Auvinen, A
    Stenman, UH
    Tammela, T
    Rannikko, S
    Aro, J
    Juusela, H
    Hakama, M
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (07) : 552 - 553
  • [8] Japanese men have smaller prostate volumes but comparable urinary flow rates relative to American men: Results of community based studies in 2 countries
    Masumori, N
    Tsukamoto, T
    Kumamoto, Y
    Miyake, H
    Rhodes, T
    Girman, CJ
    Guess, HA
    Jacobsen, SJ
    Lieber, MM
    [J]. JOURNAL OF UROLOGY, 1996, 155 (04) : 1324 - 1327
  • [9] SERUM PROSTATE-SPECIFIC ANTIGEN IN A COMMUNITY-BASED POPULATION OF HEALTHY JAPANESE MEN - LOWER VALUES THAN FOR SIMILARLY AGED WHITE MEN
    OESTERLING, JE
    KUMAMOTO, Y
    TSUKAMOTO, T
    GIRMAN, CJ
    GUESS, HA
    MASUMORI, N
    JACOBSEN, SJ
    LIEBER, MM
    [J]. BRITISH JOURNAL OF UROLOGY, 1995, 75 (03): : 347 - 353
  • [10] Serum levels of prostate-specific antigen among Japanese-American and native Japanese men
    Shibata, A
    Whittemore, AS
    Imai, K
    Kolonel, LN
    Wu, AH
    John, EH
    Stamey, TA
    Paffenbarger, RS
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (22) : 1716 - 1720